CARON, Giulia

CARON, Giulia  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 152 (tempo di esecuzione: 0.021 secondi).
Titolo Data di pubblicazione Autore(i) File
A combined in silico strategy to describe the variation of some 3D molecular properties of β-cyclodextrin due to the formation of inclusion complexes 2006 G. Ermondi; C. Anghilante; G. Caron
A comparison of calculated and experimental parameters as a source of structural information: the case of lipophilicity related descriptors 2003 G. Caron; G. Ermondi
A computational strategy to predict recognition and catalysis on recalcitrant chlorinated substrates by a catechol1,2 dioxygenase. 2010 Cecilia Rosso; Giulia Caron; Giuseppe Ermondi; Carlo Giunta; Gianfranco Gilardi; Francesca Valetti
A free web application for sharing resources about cyclodextrin/ligand complexes 2008 Ermondi G; Esposito R; Caron G
A kinetic study of the interaction between potential photosensitizers and albumin 2013 Sonja Visentin ; Nadia Barbero; Guido Viscardi ; Giulia Caron ; Giuseppe Ermondi
A Molecular-Modeling Approach to Understanding the Contributions Made by Ionization and Lipophilicity to Drug Binding to Albumin 2004 G. Ermondi; M. Lorenti; G. Caron
Access of the substrate to the active site of yeast oxidosqualene cyclase: a modelling and site-directed mutagenesis approach 2009 S. Oliaro-Bosso; S. Taramino; Y. Ferrari; G. Ermondi; G. Caron; F. Viola; G. Balliano
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin 2022 Rossi Sebastiano M.; Ermondi G.; Hadano S.; Caron G.
Airway mucus microenvironment modelling to be applied on cystic fibrosis drug discovery 2017 Petrini, P; Pacheco, Dp; Pontremoli, C.; Caron, G.; Visentin, S
An application of two MIFs-based tools (Volsurf+ and Pentacle) to binary QSAR: The case of a palinurin-related data set of non-ATP competitive Glycogen Synthase Kinase 3b (GSK-3b) inhibitors 2011 Giuseppe Ermondi; Giulia Caron; Isela Garcia Pintos; Michela Gerbaldo; Manuel Pérez; Daniel I. Pérez; Zoila Gándara; Ana Martínez; Generosa Gómez; Yagamare Fall
Application of in silico classical drug discovery tools for peptide research 2013 Ermondi, Giuseppe; Esposito, Roberto; Visconti, Alessia; Visentin, Sonja; Vallaro, Maura; Rinaldi, Laura; Caron, Giulia
APPLICATION OF IN-SILICO "CLASSICAL" DRUG DISCOVERY TOOLS TO PEPTIDE RESEARCH 2013 G. Ermondi; R. Esposito; A. Visconti; S. Visentin; M. Vallaro; L. Rinaldi; G. Caron
Are we ready to design oral PROTACs®? 2021 Jimenez D.G.; Sebastiano M.R.; Caron G.; Ermondi G.
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents (Scientific Reports, (2019), 9, 1, (3089), 10.1038/s41598-019-39510-w) 2019 Costamagna A.; Rossi Sebastiano M.; Natalini D.; Simoni M.; Valabrega G.; Defilippi P.; Visentin S.; Ermondi G.; Turco E.; Caron G.; Cabodi S.
BIOCUBE4mf 2008 G. Ermondi; G. Caron
Blended-learning for courses in Pharmaceutical Analysis 2011 Giulia Caron; Sonja Visentin; Giuseppe Ermondi
Blended-learning for courses in Pharmaceutical Analysis. Part 2 2013 Visentin S; Ermondi G; Vallaro M; Scalet G; Caron G
Block relevance (BR) analysis and polarity descriptors in property-based drug design 2018 Ermondi, Giuseppe; Caron, Giulia*
The block relevance (Br) analysis makes the choice of methods for measuring lipophilicity and permeability safer and speeds up drug candidate prioritization 2021 Caron G.; Vallaro M.; Ermondi G.
BR ANALYSIS: A TOOL TO UNRAVEL MOLECULAR INTERACTIONS BALANCE 2016 Ermondi, Giuseppe; Vallaro, Maura; Caron, Giulia